Epilepsy affects approximately one percent of the population and one in 200 children. Epilepsy syndromes with proven or likely genetic cause contribute substantially to the causes of epilepsy, especially in children. Over the last half century, there has been increasing recognition that genetic factors play an important role in predisposing individuals to epilepsy. The traditional approach of linkage analysis in families with well-defined epilepsy syndromes has been successful in identifying the genes responsible for some of these syndromes. To date, most of these genes encode ion channel subunits and provide an explanation for only a small proportion of epilepsy. We hypothesize that by studying familial forms of epilepsy with both dominant and recessive inheritance, we will discover novel genes and novel processes that set the stage for epilepsy in the developing brain. Such discovery will deepen our understanding of the developmental processes and pathways important in epilepsy and may also identify novel approaches to rational pharmacological treatment for patients with epilepsy. We will first perform rigorous phenotyping methods to classify individuals in families with individual diagnoses and familial epilepsy syndromes. We will use genome-wide markers of genetic variability (short tandem repeat polymorphisms and single nucleotide polymorphisms) to perform analyses of linkage between disease status and genomic loci, and we will further analyze the regions with evidence of linkage with positional cloning and high-throughput sequencing to identify specific genetic mutations in these families. Once this is achieved, we will screen other families and sporadic individuals with the same epilepsy phenotypes for mutations in these genes. The candidate is a board-certified child neurologist with additional clinical neurophysiology/pediatric EEG training. She will perform this research at Children's Hospital Boston under the supervision of Dr. Christopher Walsh, a renowned expert in the field of neurogenetics with extensive clinical and research experience in the genetics of brain malformations, with co-mentorship from Dr. Ruth Ottman, a pioneer in the field of epilepsy genetics who has developed the phenotyping methodologies now accepted as standard for epilepsy genetics research. In addition to the combined training under these mentors, the candidate will also participate in the Epilepsy Phenome Genome Project and receive additional training from a renowned group of national experts in epilepsy genetics. The experience and skills she will garner during this training period will set the stage for an independent career in clinical neuroscience research.

Public Health Relevance

Epilepsy is a common condition, affecting approximately one in one hundred people. While the causes of epilepsy are varied, genetics play an important role in the development of epilepsy in many individuals and may affect several individuals in a family. The goal of this project is to gain deeper insight into the fundamental causes of epilepsy by studying the genetics of familial forms of epilepsy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23NS069784-05
Application #
8628881
Study Section
NST-2 Subcommittee (NST)
Program Officer
Whittemore, Vicky R
Project Start
2010-07-01
Project End
2015-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
5
Fiscal Year
2014
Total Cost
$190,458
Indirect Cost
$14,108
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Olson, Heather; Shen, Yiping; Avallone, Jennifer et al. (2014) Copy number variation plays an important role in clinical epilepsy. Ann Neurol 75:943-58
Mirzaa, Ghayda M; Poduri, Annapurna (2014) Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology. Am J Med Genet C Semin Med Genet 166C:156-72
Zhang, Xiaochang; Ling, Jiqiang; Barcia, Giulia et al. (2014) Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. Am J Hum Genet 94:547-58
Poduri, Annapurna; Sheidley, Beth Rosen; Shostak, Sara et al. (2014) Genetic testing in the epilepsies-developments and dilemmas. Nat Rev Neurol 10:293-9
Jamuar, Saumya S; Lam, Anh-Thu N; Kircher, Martin et al. (2014) Somatic mutations in cerebral cortical malformations. N Engl J Med 371:733-43
Yu, Timothy W; Chahrour, Maria H; Coulter, Michael E et al. (2013) Using whole-exome sequencing to identify inherited causes of autism. Neuron 77:259-73
Shain, Catherine; Ramgopal, Sriram; Fallil, Zianka et al. (2013) Polymicrogyria-associated epilepsy: a multicenter phenotypic study from the Epilepsy Phenome/Genome Project. Epilepsia 54:1368-75
Poduri, Annapurna; Evrony, Gilad D; Cai, Xuyu et al. (2013) Somatic mutation, genomic variation, and neurological disease. Science 341:1237758
Gonzalez, G; Vedolin, L; Barry, B et al. (2013) Location of periventricular nodular heterotopia is related to the malformation phenotype on MRI. AJNR Am J Neuroradiol 34:877-83
Poduri, Annapurna; Evrony, Gilad D; Cai, Xuyu et al. (2012) Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 74:41-8

Showing the most recent 10 out of 13 publications